{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:14:04Z","timestamp":1779394444335,"version":"3.53.1"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.3201\/eid3206.260135","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:42:13Z","timestamp":1779392533000},"source":"Crossref","is-referenced-by-count":0,"title":["In Vitro Antifungal Drug Susceptibility of Feline\n                    <i>Sporothrix schenckii<\/i>\n                    Complex Isolates, Thailand, 2023\u20132025"],"prefix":"10.3201","volume":"32","author":[{"given":"Chompoonek","family":"Yurayart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokporn","family":"Yingchanakiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amonrat","family":"Thongbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orawan","family":"Limsivilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathidpak Nantasanti","family":"Assawarachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassanee","family":"Jaroensong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpicha","family":"Sattasathuchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3206.260135-202605211541-R1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.riam.2013.09.008","article-title":"Molecular identification of the Sporothrix schenckii complex.","volume":"31","author":"Oliveira","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/mmy\/myu062","article-title":"Global epidemiology of sporotrichosis.","volume":"53","author":"Chakrabarti","year":"2015","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/jof7030170","article-title":"Sporothrix brasiliensis: a review of an emerging South American fungal pathogen, its related disease, presentation and spread in Argentina.","volume":"7","author":"Etchecopaz","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3206.260135-202605211541-R4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/17460913.2024.2352283","article-title":"Current situation of sporotrichosis in China.","volume":"19","author":"Cheng","year":"2024","journal-title":"Future Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s42770-020-00346-6","article-title":"Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.","volume":"52","author":"Rudramurthy","year":"2021","journal-title":"Braz J Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/jof9050590","article-title":"Phenotypic and genotypic characterization and antifungal susceptibility of Sporothrix schenckii sensu stricto isolated from a feline sporotrichosis outbreak in Bangkok, Thailand.","volume":"9","author":"Yingchanakiat","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3206.260135-202605211541-R7","doi-asserted-by":"publisher","first-page":"e0013253","DOI":"10.1371\/journal.pntd.0013253","article-title":"Targeted long-read sequencing analysis and antifungal susceptibility profiles of Sporothrix schenckii isolates from Thailand.","volume":"19","author":"Langsiri","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid3206.260135-202605211541-R8","doi-asserted-by":"publisher","first-page":"myac075","DOI":"10.1093\/mmy\/myac075","article-title":"Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.","volume":"60","author":"Indoung","year":"2022","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R9","doi-asserted-by":"publisher","first-page":"e1006077","DOI":"10.1371\/journal.ppat.1006077","article-title":"Zoonotic epidemic of sporotrichosis: cat to human transmission.","volume":"13","author":"Gremi\u00e3o","year":"2017","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid3206.260135-202605211541-R10","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3201\/eid3012.240467","article-title":"Clinical manifestations, antifungal drug susceptibility, and treatment outcomes for emerging zoonotic cutaneous sporotrichosis, Thailand.","volume":"30","author":"Jirawattanadon","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3206.260135-202605211541-R11","doi-asserted-by":"publisher","first-page":"893501","DOI":"10.3389\/fcimb.2022.893501","article-title":"Sporotrichosis caused by non-wild type Sporothrix brasiliensis strains.","volume":"12","author":"Bernardes-Engemann","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s42770-020-00307-z","article-title":"Antifungal resistance on Sporothrix species: an overview.","volume":"52","author":"Waller","year":"2021","journal-title":"Braz J Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.riam.2022.05.002","article-title":"Advances and challenges in the management of feline sporotrichosis.","volume":"39","author":"Gremi\u00e3o","year":"2022","journal-title":"Rev Iberoam Micol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s42770-020-00365-3","article-title":"Guideline for the management of feline sporotrichosis caused by Sporothrix brasiliensis and literature revision.","volume":"52","author":"Gremi\u00e3o","year":"2021","journal-title":"Braz J Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s42770-020-00290-5","article-title":"Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection.","volume":"52","author":"Nakasu","year":"2021","journal-title":"Braz J Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R16","unstructured":"Larsson CE. Sporotrichosis and cryptococcosis. Presented at: World Small Animal Veterinary Association Congress; Mexico City, Mexico; 2005 May 11\u201314."},{"key":"key-10.3201\/eid3206.260135-202605211541-R17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2460\/javma.23.05.0276","article-title":"Oral voriconazole therapy in cats with histoplasmosis yielded mild side effects and a favorable outcome.","volume":"261","author":"Easterwood","year":"2023","journal-title":"J Am Vet Med Assoc"},{"key":"key-10.3201\/eid3206.260135-202605211541-R18","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1038\/s41598-025-87711-3","article-title":"Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine.","volume":"15","author":"Aroonvuthiphong","year":"2025","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid3206.260135-202605211541-R19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2327-5073.1000145","article-title":"In vitro Antifungal susceptibility testing of 5 antifungal agents against dermatophytic species by CLSI (M38-A) micro dilution method.","volume":"3","author":"Indira","year":"2014","journal-title":"Clin Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R20","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed. M38. Wayne (PA): The Institute; 2017."},{"key":"key-10.3201\/eid3206.260135-202605211541-R21","doi-asserted-by":"publisher","first-page":"e01057","DOI":"10.1128\/AAC.01057-17","article-title":"Multicenter, international study of MIC\/MEC Distributions for definition of epidemiological cutoff values for Sporothrix species identified by molecular methods.","volume":"61","author":"Espinel-Ingroff","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3206.260135-202605211541-R22","unstructured":"Clinical and Laboratory Standards Institute. Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing. Wayne (PA): The Institute; 2016."},{"key":"key-10.3201\/eid3206.260135-202605211541-R23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12917-021-02965-z","article-title":"Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand.","volume":"17","author":"Inpankaew","year":"2021","journal-title":"BMC Vet Res"},{"key":"key-10.3201\/eid3206.260135-202605211541-R24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0034-5288(96)90067-3","article-title":"Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus.","volume":"61","author":"Hoffmann-Fezer","year":"1996","journal-title":"Res Vet Sci"},{"key":"key-10.3201\/eid3206.260135-202605211541-R25","doi-asserted-by":"publisher","first-page":"myac009","DOI":"10.1093\/mmy\/myac009","article-title":"Comparative evaluation of Sensititre YeastOne and VITEK 2 against the clinical and laboratory standards institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii.","volume":"60","author":"Zhang","year":"2022","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R26","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.01176-06","article-title":"In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.","volume":"51","author":"Alvarado-Ram\u00edrez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3206.260135-202605211541-R27","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-199013\/v1","article-title":"Amran Fb, Sukur SbM, Shukor Sb. Susceptibility of filamentous fungi to voriconazole in Malaysia tested by Sensititre YeastOne and CLSI mirocilution methods.","author":"Tan","year":"2021","journal-title":"Research Square"},{"key":"key-10.3201\/eid3206.260135-202605211541-R28","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of clinical and laboratory standards institute broth microdilution methods, 2010 to 2012.","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R29","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1128\/AAC.00686-11","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3206.260135-202605211541-R30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2460\/javma.252.2.195","article-title":"Comparison of absorption characteristics of oral reference and compounded itraconazole formulations in healthy cats.","volume":"252","author":"Mawby","year":"2018","journal-title":"J Am Vet Med Assoc"},{"key":"key-10.3201\/eid3206.260135-202605211541-R31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1098612X13489225","article-title":"Sporotrichosis in cats: ABCD guidelines on prevention and management.","volume":"15","author":"Lloret","year":"2013","journal-title":"J Feline Med Surg"},{"key":"key-10.3201\/eid3206.260135-202605211541-R32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0014-5793(96)01360-9","article-title":"Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.","volume":"400","author":"Kelly","year":"1997","journal-title":"FEBS Lett"},{"key":"key-10.3201\/eid3206.260135-202605211541-R33","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1128\/JCM.36.9.2690-2695.1998","article-title":"Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.","volume":"36","author":"Vazquez","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3206.260135-202605211541-R34","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1086\/522765","article-title":"Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.","volume":"45","author":"Kauffman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3206.260135-202605211541-R35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1751-0813.2011.00804.x","article-title":"Treatment of refractory feline sporotrichosis with a combination of intralesional amphotericin B and oral itraconazole.","volume":"89","author":"Gremi\u00e3o","year":"2011","journal-title":"Aust Vet J"},{"key":"key-10.3201\/eid3206.260135-202605211541-R36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11046-010-9380-8","article-title":"Comparative study of 250 mg\/day terbinafine and 100 mg\/day itraconazole for the treatment of cutaneous sporotrichosis.","volume":"171","author":"Francesconi","year":"2011","journal-title":"Mycopathologia"},{"key":"key-10.3201\/eid3206.260135-202605211541-R37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11046-017-0225-6","article-title":"Successful treatment of canine sporotrichosis with terbinafine: case reports and literature review.","volume":"183","author":"Viana","year":"2018","journal-title":"Mycopathologia"},{"key":"key-10.3201\/eid3206.260135-202605211541-R38","doi-asserted-by":"publisher","first-page":"e4435","DOI":"10.1002\/vetr.4435","article-title":"Is terbinafine an effective treatment for feline sporotrichosis?","volume":"195","author":"Viana","year":"2024","journal-title":"Vet Rec"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:42:15Z","timestamp":1779392535000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/6\/26-0135_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3206.260135","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}